Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

ImmunGene
558 St. Charles Dr. Suite 200
Thousand Oaks, CA 91360
Phone: 805-496-6700
www.immungene.com

ImmunGene is a privately held biotechnology company focused on the development of proprietary antibody-cytokine fusion technology and monoclonal antibody-based therapies to treat cancer, autoimmune disorders, and other diseases. ImmunGene has several programs at various stages of development. ImmunGene is funded by federal government grants including the NIH-SBIR and by private investors including several biotechnology executives.

Key Contact
Name
Sanjay D. Khare
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
11/07/13 $9,000,000 Series A Ally Bridge Group
undisclosed